Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029835 · ClinicalTrials.gov registry record · Phase 3
Obese Patients With Untreated Dyslipidemias
A Phase 3 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,033
- Enrollment target
NCT00029835 is a Phase 3 study that has completed, run by Sanofi. The registered enrollment target is 1,033 participants.
The verdict
NCT00029835, a Phase 3 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,033 participants
- Enrollment target
Study Summary
To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with untreated dyslipidemia
Interventions
- DRUG Rimonabant (SR141716)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,033 participants |
| Start Date | 2001-09 |
| Est. Completion | 2003-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00029835
The ClinicalTrials.gov registry entry for NCT00029835 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,033 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rimonabant (SR141716) is the first listed.
NCT00029835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00029835 about?
NCT00029835 is a clinical study titled "Obese Patients With Untreated Dyslipidemias". To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with untreated dyslipidemia
What is the current status of trial NCT00029835?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,033 participants. The study started on 2001-09. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00029835?
The interventions under investigation include: Rimonabant (SR141716) (DRUG).
Who is sponsoring clinical trial NCT00029835?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.